FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000147832> ?p ?o ?g. }

• W3000147832 endingPage "e000807" @default.
• W3000147832 startingPage "e000807" @default.
• W3000147832 abstract "Objective To compare the efficacy and safety of an initial triple therapy using metformin, a dipeptidyl peptidase-4 (DPP4) inhibitor, and thiazolidinedione with a stepwise approach using sulfonylurea and metformin in new-onset, drug-naïve patients with type 2 diabetes. Research design and methods Among drug-naïve patients with 9.0%–12.0% glycated hemoglobin (HbA1c) but no hyperglycemic symptoms, 100 subjects who started triple medications (metformin 1000 mg/day, sitagliptin 100 mg/day, and lobeglitazone 0.5 mg/day) were selected as an initial triple therapy group. Age and body mass index-matched subjects (n=100) who started glimepiride (≥2 mg/day with uptitration) and metformin (≥1000 mg/day with uptitration) were selected as a conventional therapy group. We investigated changes in HbA1c level, dynamic indexes for insulin sensitivity and β-cell function, and hypoglycemia. Results After 12 months of treatment, HbA1c levels decreased significantly in both groups: from 10.7%±1.0% to 6.7%±1.3% in the triple group, and from 10.5%±1.0% to 7.3%±1.2% in the conventional therapy group. At 12 months, achievement of the HbA1c target (<7.0%) was higher in the triple group than in the conventional group (70% vs 52%, p<0.01). Dynamic indexes related to β-cell function and insulin sensitivity improved, and albuminuria reduced significantly only in the triple group. Hypoglycemia was more common in the conventional group. Conclusions Initial triple combination therapy with the DPP4 inhibitor, metformin, and thiazolidinedione showed a higher achievement of the target HbA1c goal with a lower risk of hypoglycemia, better restoration of β-cell function, and multiple metabolic benefits, implying durable glycemic control. This strategy may be useful for patients presenting with type 2 diabetes and high HbA1c levels." @default.
• W3000147832 created "2020-01-23" @default.
• W3000147832 creator A5006525512 @default.
• W3000147832 creator A5009982632 @default.
• W3000147832 creator A5043366285 @default.
• W3000147832 creator A5057474625 @default.
• W3000147832 creator A5065911154 @default.
• W3000147832 creator A5071083018 @default.
• W3000147832 creator A5084593004 @default.
• W3000147832 date "2020-01-01" @default.
• W3000147832 modified "2023-10-17" @default.
• W3000147832 title "Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study" @default.
• W3000147832 cites W1576760610 @default.
• W3000147832 cites W172609984 @default.
• W3000147832 cites W1975588287 @default.
• W3000147832 cites W1981713709 @default.
• W3000147832 cites W2009165325 @default.
• W3000147832 cites W2029228033 @default.
• W3000147832 cites W2038103428 @default.
• W3000147832 cites W2041375230 @default.
• W3000147832 cites W2044435399 @default.
• W3000147832 cites W2060716197 @default.
• W3000147832 cites W2061524651 @default.
• W3000147832 cites W2064617441 @default.
• W3000147832 cites W2066816981 @default.
• W3000147832 cites W2073578030 @default.
• W3000147832 cites W2081276121 @default.
• W3000147832 cites W2106626737 @default.
• W3000147832 cites W2108646653 @default.
• W3000147832 cites W2109416725 @default.
• W3000147832 cites W2109451951 @default.
• W3000147832 cites W2109728760 @default.
• W3000147832 cites W2117908310 @default.
• W3000147832 cites W2124977666 @default.
• W3000147832 cites W2126327417 @default.
• W3000147832 cites W2127018329 @default.
• W3000147832 cites W2132806782 @default.
• W3000147832 cites W2133795831 @default.
• W3000147832 cites W2136788080 @default.
• W3000147832 cites W2140183516 @default.
• W3000147832 cites W2146264128 @default.
• W3000147832 cites W2159969745 @default.
• W3000147832 cites W2160234571 @default.
• W3000147832 cites W2164364203 @default.
• W3000147832 cites W2171294019 @default.
• W3000147832 cites W2302447233 @default.
• W3000147832 cites W2607031541 @default.
• W3000147832 cites W2626446274 @default.
• W3000147832 cites W2767062006 @default.
• W3000147832 cites W2769250691 @default.
• W3000147832 cites W2769264260 @default.
• W3000147832 cites W2789940461 @default.
• W3000147832 cites W2894993577 @default.
• W3000147832 cites W2900413769 @default.
• W3000147832 cites W4251240079 @default.
• W3000147832 doi "https://doi.org/10.1136/bmjdrc-2019-000807" @default.
• W3000147832 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7039575" @default.
• W3000147832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31958303" @default.
• W3000147832 hasPublicationYear "2020" @default.
• W3000147832 type Work @default.
• W3000147832 sameAs 3000147832 @default.
• W3000147832 citedByCount "12" @default.
• W3000147832 countsByYear W30001478322020 @default.
• W3000147832 countsByYear W30001478322021 @default.
• W3000147832 countsByYear W30001478322022 @default.
• W3000147832 countsByYear W30001478322023 @default.
• W3000147832 crossrefType "journal-article" @default.
• W3000147832 hasAuthorship W3000147832A5006525512 @default.
• W3000147832 hasAuthorship W3000147832A5009982632 @default.
• W3000147832 hasAuthorship W3000147832A5043366285 @default.
• W3000147832 hasAuthorship W3000147832A5057474625 @default.
• W3000147832 hasAuthorship W3000147832A5065911154 @default.
• W3000147832 hasAuthorship W3000147832A5071083018 @default.
• W3000147832 hasAuthorship W3000147832A5084593004 @default.
• W3000147832 hasBestOaLocation W30001478321 @default.
• W3000147832 hasConcept C126322002 @default.
• W3000147832 hasConcept C126894567 @default.
• W3000147832 hasConcept C134018914 @default.
• W3000147832 hasConcept C2776923340 @default.
• W3000147832 hasConcept C2777180221 @default.
• W3000147832 hasConcept C2777538456 @default.
• W3000147832 hasConcept C2778763485 @default.
• W3000147832 hasConcept C2778854520 @default.
• W3000147832 hasConcept C2779284873 @default.
• W3000147832 hasConcept C2779306644 @default.
• W3000147832 hasConcept C2780323712 @default.
• W3000147832 hasConcept C2780668416 @default.
• W3000147832 hasConcept C2910260750 @default.
• W3000147832 hasConcept C555293320 @default.
• W3000147832 hasConcept C71924100 @default.
• W3000147832 hasConcept C90924648 @default.
• W3000147832 hasConcept C98274493 @default.
• W3000147832 hasConceptScore W3000147832C126322002 @default.
• W3000147832 hasConceptScore W3000147832C126894567 @default.
• W3000147832 hasConceptScore W3000147832C134018914 @default.
• W3000147832 hasConceptScore W3000147832C2776923340 @default.
• W3000147832 hasConceptScore W3000147832C2777180221 @default.
• W3000147832 hasConceptScore W3000147832C2777538456 @default.

• next